Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1149120220190010027
Journal of the Korean Society for Psoriasis
2022 Volume.19 No. 1 p.27 ~ p.29
Psoriasis Exacerbation after Pfizer-BioNTech COVID-19 mRNA Vaccine
Cho Min-Kyung

Kim Dong-Hyun
Abstract
There has been a rising number of case reports regarding flares of pre-existing dermatoses after COVID-19 vaccination. Still unclear, the exacerbation seems to be associated with an immune-mediated mechanism, probably due to both infectious components of the vaccine and its adjuvants. Furthermore, vaccine-induced immune enhancement may play a role. Herein, we report a case of a 23-year-old male patient with a previous history of psoriasis. He experienced an exacerbation of psoriasis seven days after the second administration of the Pfizer-BioNTech vaccination, gradually spreading on whole body. The patient didn¡¯t receive further vaccination, and the symptom was relieved after five months of cyclosporine treatments. This case report highlights COVID-19 vaccination as a medication that can exacerbate psoriasis, and further studies are needed to elucidate the causal relationship.
KEYWORD
COVID-19, COVID-19 vaccine, Exacerbation, Psoriasis
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)